Do clinical scales of balance reflect turning abnormalities in people with Parkinson’s disease?

Por King, LA, Mancini, M, Priest, K, Salarian, A, Rodrigues-de-Paula, F, Horak, F
Publicado em 2012

A pilot study of mitomycin, cisplatin and continuous infusion 5-fluorouracil (MCF) in advanced non-small-cell lung cancer.

Por Ellis, P. A., Talbot, D. C., Nicolson, M. C., Priest, K., Ashley, S., Smith, I. E.
Publicado em 1995

Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer.

Por Ellis, P. A., Smith, I. E., Hardy, J. R., Nicolson, M. C., Talbot, D. C., Ashley, S. E., Priest, K.
Publicado em 1995

Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?

Por Ross, P J, Ashley, S, Norton, A, Priest, K, Waters, J S, Eisen, T, Smith, I E, O'Brien, M E R
Publicado em 2004

A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer.

Por Hickish, T. F., Smith, I. E., Nicolson, M. C., Ashley, S., Priest, K., Spencer, L., Norman, A., Middleton, G., O'Brien, M. E.
Publicado em 1998

Exploring Outcome Measures for Exercise Intervention in People with Parkinson's Disease

Por King, L. A., Salarian, A., Mancini, M., Priest, K. C., Nutt, J., Serdar, A., Wilhelm, J., Schlimgen, J., Smith, M., Horak, F. B.
Publicado em 2013

Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer.

Por Modjtahedi, H., Hickish, T., Nicolson, M., Moore, J., Styles, J., Eccles, S., Jackson, E., Salter, J., Sloane, J., Spencer, L., Priest, K., Smith, I., Dean, C., Gore, M.
Publicado em 1996

A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma

Por O’Brien, M E R, Saini, A, Smith, I E, Webb, A, Gregory, K, Mendes, R, Ryan, C, Priest, K, Bromelow, K V, Palmer, R D, Tuckwell, N, Kennard, D A, Souberbielle, B E
Publicado em 2000